2017-08-31 12:30 Episurf Medical’s 50th Episealer® implant in Belgium Episurf Medical announces that the 50th implantation of the Episealer® knee implant in Belgium will take place in […]
2017-08-31 06:46 Xbrane Biopharma releases interim report for the period April - June 2017 Xbrane Biopharma ABs interim report for the period April – June 2017 is now available on the Company’s […]
2017-08-30 12:23 IRRAS Appoints Fredrik Alpsten as Chief Financial Officer and Deputy CEO -Mr. Alpsten will Lead the Development of IRRAS’ Global Finance Strategies- Stockholm, Sweden August 30, 2017 – IRRAS, […]
2017-08-29 06:45 Diamorph AB (publ): Interim report second quarter 2017 Second quarter The results for the second quarter should be considered against a strong comparative in the second […]
2017-08-25 13:19 Organoclick AB (Publ) publishes its interim report for Q2 2017 “During the second quarter our positive trend from the first quarter continued. Sales increased from SEK 17.1 million […]
2017-08-25 06:38 Episurf Medical AB will exhibit at the 34th AGA Congress held in Munich, Germany, on September 7-9 Episurf Medical (NASDAQ: EPIS B) will exhibit at the 34th AGA Congress (Society for Arthroscopy and Joint Surgery, […]
2017-08-22 19:38 Information about ongoing discussions and negotiations concerning out-licensing of Xbrane Biopharma AB's (Publ) products Press release 2017-08-22 In accordance with what has previously been communicated in press releases, interim reports and presentations, […]
2017-08-22 19:30 Episurf Medical AB will exhibit at SOF 2017, held in Umeå, Sweden on August 29 - September 1 Episurf Medical AB will exhibit at SOF 2017 (Swedish Orthopaedic Society), an orthopaedic conference, held in Umeå, Sweden […]
2017-08-18 07:49 Episurf Medical Interim Report 1 April - 30 June 2017 Second quarter 2017, compared to 2016, Group » Group net sales increased by 33% to SEK 622,897 (469,380) […]
2017-08-16 08:27 Episurf Medical reaches milestone of 250 implants Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached another milestone by planning of its 250th […]
2017-08-10 12:39 Diamorph AB (publ) to redeem its outstanding bonds in their entirety Redemption of bonds Diamorph AB (publ) (the “ Company ”) has given notice that it is exercising its […]
2017-07-26 12:32 Management group changes in Episurf Medical Episurf Medical (NASDAQ: EPIS B) today announces that Dan Griffiths, Head of Marketing, will leave the company during […]
2017-07-24 08:59 Xbrane Biopharma AB: Spherotide granted Market Authorization in Iran Xbranes partner Pooyesh Darou has been granted Market Authorization for sales and marketing of Spherotide 1 month formulation […]
2017-07-20 09:31 Episurf Medical reports brief clinical update Episurf Medical’s (NASDAQ: EPIS B) first 15 patients have now had their Episealer® implants for more than 3 […]
2017-07-20 09:30 Episurf Medical has become an approved supplier to Spire Healthcare, one of the UK’s largest independent hospital providers Episurf Medical (NASDAQ: EPIS B) has become an approved supplier to Spire Healthcare, one of the UK’s largest […]
2017-07-19 09:29 Another preclinical paper on the Episealer implant published Another preclinical paper has been published that again validates Episurf Medical’s (NASDAQ: EPIS B) patented cartilage repair technology […]
2017-07-11 13:08 Case-report with clinical data of Episealer patient published A peer-reviewed report from a case-study with clinical data of an Episealer patient has been published in the […]
2017-07-11 13:06 Episurf Medical: Dennis D. Stripe to re-assume the position as Non-executive Chairman of the Board In conjunction to the change in the leadership of Episurf Medical (NASDAQ: EPIS B) January 5 2017, Dennis […]
2017-07-07 12:45 Complementary information on Xbrane Biopharma AB's (publ) long-term share savings program for employees On 14 June, 2017 Xbrane Biopharma AB (publ) announced that the Company had launched a long-term share savings […]
2017-06-30 14:00 OrganoClick selected to achieve the United Nation’s sustainable development goals Following a global search, OrganoClick has been selected as one of 16 companies to lead global business in […]
2017-06-21 09:22 Insider transactions in Episurf Medical Episurf Medical’s (NASDAQ: EPIS B) Chairman of the Board Dennis D. Strupe acquired shares in Episurf Medical on […]
2017-06-16 14:29 OrganoClick has been granted SEK 2.3 million by Vinnova for the development of a biocomposite material for furniture and furnishings in public spaces OrganoClick has been granted SEK 2.3 million by Vinnova for the development of a biocomposite material for furniture […]
2017-06-12 11:59 Episurf Medical obtains further granted patent in Europe The European patent office EPO has announced its intention to grant another European patent for Episurf Medical. The […]
2017-06-07 09:48 Episurf Medical appoints Dr Michael Manley special advisor for US strategy Episurf Medical (NASDAQ: EPIS B) today announced that it has appointed Dr Michael Manley as special advisor in […]
2017-06-02 14:41 Episurf Medical's Board names Pål Ryfors new CEO and appoints new CFO Episurf Medical’s board today announced that its Board of Directors has appointed Pål Ryfors CEO, effective immediately. Executive […]
2017-05-31 12:23 Resolutions at OrganoClick Annual General Meeting OrganoClick AB (publ) held its Annual General Meeting, 30 May 2017 at the company’s head office in Täby […]
2017-05-24 08:15 Xbrane Biopharma announces a directed new share issue of SEK 20 million Today, the Board of Directors of Xbrane Biopharma AB (“Xbrane” or the “Company”), with authorization granted by the […]
2017-05-22 21:00 Summary from Annual General Meeting of Episurf Medical AB (publ) The shareholders of Episurf Medical AB (publ) (“Episurf” or the “Company”) gathered in Stockholm, Sweden, on Monday 22 […]
2017-05-22 14:23 Minutes from Xbrane Biopharma AB's (publ) Annual General Meeting The shareholders of Xbrane Biopharma AB (publ) gathered in Stockholm, Sweden, 18 May 2017 for the Annual General […]
2017-05-22 09:45 OrganoClick’s subsidiary OrganoWood gets its biggest project order ever OrganoClick’s subsidiary OrganoWood has received its biggest single project order ever. For the construction of a new office […]
